Vilin Bio Med Announces Financial Results and Details Funds Utilization from Preferential Issue

Vilin Bio Med Announces Financial Results and Details Funds Utilization from Preferential Issue

Vilin Bio Med Announces Financial Results and Details Funds Utilization from Preferential Issue​

Vilin Bio Med Limited released its Standalone Financial Results for the year ended March 31, 2026, alongside updates regarding its capital structure. The company also provided a detailed breakdown of the utilization of funds raised through a recent Preferential Issue.

The Company reported results for the Half-year and Year ended March 31, 2026, as well as the Year-to-date results for the period from April 1, 2025, to March 31, 2026.

In terms of capital transactions, Vilin Bio Med allotted 13,00,000 Equity Shares to Ti Reddy at a face value of Rs. 10/- and a premium of Rs. 16/- Per Share.

Financial Highlights​

The financial results provide a detailed overview of the Company's operational performance. Key financial metrics for the half-year ended March 31, 2026, include:

ItemAmount (₹)
Revenue from Operations3,260.02
Total Expenses966.40
Profit (A)21.03
Profit (B)55.80
Profit (A+B)6.77

The table below details the full financial year results and associated metrics:

ItemYear Ended March 31, 2026Year Ended March 31, 2025
Revenue from Operations52.3517.78
Cost of Goods Sold2,995.31947.02
Employee Benefits Expenses264.7119.38
Exceptional Items and Tax--
Total Expenses264.7119.38
Profit (A)83.204.63

Funds Utilization and Capital Structure​

Vilin Bio Med Limited successfully completed a Preferential Issue on March 4, 2026, raising a total amount of Rs. 338.00 Lakhs.

The total fundraising amount was originally allocated across two main objectives:
  • Working Capital: Rs. 327 Lakhs
  • Issue Expenses: Rs. 11 Lakhs
  • Total Original Allocation: Rs. 338 Lakhs

The Company reported no deviation in the objects for which the funds were raised. However, the utilization details show that a total of Rs. 197.93 Lakhs was utilized, comprising:
  • Working Capital utilized: Rs. 187.05 Lakhs
  • Issue Expenses utilized: Rs. 10.88 Lakhs

The remaining balance amount of Rs. 140.07 Lakhs is currently maintained with a Scheduled Commercial Bank.

VILINBIO Stock Price Movement​

Vilin Bio Med Limited shares slipped by 2.00% on Friday, closing at ₹46.55. The stock shed ₹0.95 during the session, settling below the previous day's close of ₹47.5.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Back
Top